A universal vaccine for serogroup B meningococcus.

By M. Giuliani, J. Adu‐Bobie, M. Comanducci, B. Aricó, S. Savino, L. Santini, B. Brunelli, S. Bambini, A. Biolchi, B. Capecchi and 20 more. Proceedings of the National Academy of Sciences of the United States of America, 2006

762 citations recorded by the source corpus.

Subfields: Epidemiology, Microbiology

View Paper: https://www.semanticscholar.org/paper/a43c7f32dbc13278aa73fa15abf193fafb7244fc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Vladimir Li
2. Chul Lee
3. Seoae Cho
4. DongAhn Yoo
5. Heebal Kim

Citations in the corpus

• In silico SARS-CoV-2 vaccine development for Omicron strain using reverse vaccinology (2022, methodology): “As an example, reverse vaccinology was successfully used for the development of 4CMenB vaccine against meningococcal group B bacteria (Giuliani et al. 2022).”